nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—thyroid gland—thyroid cancer	0.0152	0.137	CbGeAlD
Azacitidine—DNMT1—saliva-secreting gland—thyroid cancer	0.0151	0.136	CbGeAlD
Azacitidine—CDA—thyroid gland—thyroid cancer	0.0144	0.129	CbGeAlD
Azacitidine—DNMT3A—head—thyroid cancer	0.0135	0.121	CbGeAlD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.0117	0.274	CbGpPWpGaD
Azacitidine—DNMT1—trachea—thyroid cancer	0.0116	0.105	CbGeAlD
Azacitidine—DNMT3A—lymph node—thyroid cancer	0.00945	0.085	CbGeAlD
Azacitidine—DNMT1—thyroid gland—thyroid cancer	0.0092	0.0827	CbGeAlD
Azacitidine—CDA—lymph node—thyroid cancer	0.00893	0.0803	CbGeAlD
Azacitidine—DNMT1—head—thyroid cancer	0.00816	0.0734	CbGeAlD
Azacitidine—DNMT3A—Chromatin modifying enzymes—MBIP—thyroid cancer	0.00633	0.148	CbGpPWpGaD
Azacitidine—DNMT1—lymph node—thyroid cancer	0.00571	0.0514	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.00538	0.126	CbGpPWpGaD
Azacitidine—Adenosine triphosphate—AKT1—thyroid cancer	0.003	1	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	0.00169	0.0395	CbGpPWpGaD
Azacitidine—CDA—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00143	0.0334	CbGpPWpGaD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—thyroid cancer	0.00135	0.0315	CbGpPWpGaD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—PPARG—thyroid cancer	0.00123	0.0288	CbGpPWpGaD
Azacitidine—DNMT3A—RMTs methylate histone arginines—CCND1—thyroid cancer	0.00117	0.0274	CbGpPWpGaD
Azacitidine—Coma—Epirubicin—thyroid cancer	0.00105	0.00125	CcSEcCtD
Azacitidine—Vomiting—Vandetanib—thyroid cancer	0.00105	0.00124	CcSEcCtD
Azacitidine—Ecchymosis—Epirubicin—thyroid cancer	0.00104	0.00123	CcSEcCtD
Azacitidine—Neoplasm—Epirubicin—thyroid cancer	0.00104	0.00123	CcSEcCtD
Azacitidine—Melaena—Doxorubicin—thyroid cancer	0.00104	0.00123	CcSEcCtD
Azacitidine—Rash—Vandetanib—thyroid cancer	0.00104	0.00123	CcSEcCtD
Azacitidine—Dermatitis—Vandetanib—thyroid cancer	0.00104	0.00123	CcSEcCtD
Azacitidine—Headache—Vandetanib—thyroid cancer	0.00103	0.00122	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00101	0.0012	CcSEcCtD
Azacitidine—Sepsis—Epirubicin—thyroid cancer	0.000998	0.00118	CcSEcCtD
Azacitidine—Dyspnoea—Sorafenib—thyroid cancer	0.00099	0.00117	CcSEcCtD
Azacitidine—Lymphadenopathy—Epirubicin—thyroid cancer	0.000979	0.00116	CcSEcCtD
Azacitidine—Nausea—Vandetanib—thyroid cancer	0.000978	0.00116	CcSEcCtD
Azacitidine—Dyspepsia—Sorafenib—thyroid cancer	0.000978	0.00116	CcSEcCtD
Azacitidine—Coma—Doxorubicin—thyroid cancer	0.000973	0.00115	CcSEcCtD
Azacitidine—Decreased appetite—Sorafenib—thyroid cancer	0.000966	0.00115	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—TRIM33—thyroid cancer	0.000963	0.0225	CbGpPWpGaD
Azacitidine—Neoplasm—Doxorubicin—thyroid cancer	0.000962	0.00114	CcSEcCtD
Azacitidine—Ecchymosis—Doxorubicin—thyroid cancer	0.000962	0.00114	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000959	0.00114	CcSEcCtD
Azacitidine—Fatigue—Sorafenib—thyroid cancer	0.000958	0.00114	CcSEcCtD
Azacitidine—Pain—Sorafenib—thyroid cancer	0.00095	0.00113	CcSEcCtD
Azacitidine—Constipation—Sorafenib—thyroid cancer	0.00095	0.00113	CcSEcCtD
Azacitidine—CDA—Metabolism—MINPP1—thyroid cancer	0.000948	0.0221	CbGpPWpGaD
Azacitidine—Vascular purpura—Epirubicin—thyroid cancer	0.000934	0.00111	CcSEcCtD
Azacitidine—Hepatic failure—Epirubicin—thyroid cancer	0.000929	0.0011	CcSEcCtD
Azacitidine—Sepsis—Doxorubicin—thyroid cancer	0.000924	0.0011	CcSEcCtD
Azacitidine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000921	0.00109	CcSEcCtD
Azacitidine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000908	0.00108	CcSEcCtD
Azacitidine—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000906	0.00107	CcSEcCtD
Azacitidine—Urticaria—Sorafenib—thyroid cancer	0.000882	0.00105	CcSEcCtD
Azacitidine—Body temperature increased—Sorafenib—thyroid cancer	0.000878	0.00104	CcSEcCtD
Azacitidine—Abdominal pain—Sorafenib—thyroid cancer	0.000878	0.00104	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—CCND1—thyroid cancer	0.000878	0.0205	CbGpPWpGaD
Azacitidine—Purpura—Epirubicin—thyroid cancer	0.000866	0.00103	CcSEcCtD
Azacitidine—Vascular purpura—Doxorubicin—thyroid cancer	0.000864	0.00102	CcSEcCtD
Azacitidine—Hepatic failure—Doxorubicin—thyroid cancer	0.00086	0.00102	CcSEcCtD
Azacitidine—Cardiac failure—Epirubicin—thyroid cancer	0.000856	0.00102	CcSEcCtD
Azacitidine—Lethargy—Epirubicin—thyroid cancer	0.000852	0.00101	CcSEcCtD
Azacitidine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000852	0.00101	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000835	0.000991	CcSEcCtD
Azacitidine—Pain in extremity—Epirubicin—thyroid cancer	0.000835	0.000991	CcSEcCtD
Azacitidine—Hypersensitivity—Sorafenib—thyroid cancer	0.000818	0.000971	CcSEcCtD
Azacitidine—CDA—Metabolism—NDUFA13—thyroid cancer	0.000806	0.0188	CbGpPWpGaD
Azacitidine—Purpura—Doxorubicin—thyroid cancer	0.000802	0.000951	CcSEcCtD
Azacitidine—Asthenia—Sorafenib—thyroid cancer	0.000797	0.000945	CcSEcCtD
Azacitidine—Cardiac failure—Doxorubicin—thyroid cancer	0.000792	0.000939	CcSEcCtD
Azacitidine—Lethargy—Doxorubicin—thyroid cancer	0.000789	0.000935	CcSEcCtD
Azacitidine—Pruritus—Sorafenib—thyroid cancer	0.000786	0.000932	CcSEcCtD
Azacitidine—Dehydration—Epirubicin—thyroid cancer	0.000777	0.000921	CcSEcCtD
Azacitidine—Pain in extremity—Doxorubicin—thyroid cancer	0.000773	0.000917	CcSEcCtD
Azacitidine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000773	0.000917	CcSEcCtD
Azacitidine—Dry skin—Epirubicin—thyroid cancer	0.000766	0.000908	CcSEcCtD
Azacitidine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000763	0.000905	CcSEcCtD
Azacitidine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000763	0.000905	CcSEcCtD
Azacitidine—Hypokalaemia—Epirubicin—thyroid cancer	0.00076	0.000902	CcSEcCtD
Azacitidine—Diarrhoea—Sorafenib—thyroid cancer	0.00076	0.000901	CcSEcCtD
Azacitidine—CDA—Metabolism—CHST14—thyroid cancer	0.000758	0.0177	CbGpPWpGaD
Azacitidine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000747	0.000886	CcSEcCtD
Azacitidine—Muscular weakness—Epirubicin—thyroid cancer	0.000737	0.000874	CcSEcCtD
Azacitidine—Dizziness—Sorafenib—thyroid cancer	0.000734	0.000871	CcSEcCtD
Azacitidine—Abdominal distension—Epirubicin—thyroid cancer	0.000727	0.000862	CcSEcCtD
Azacitidine—Dysphagia—Epirubicin—thyroid cancer	0.000722	0.000856	CcSEcCtD
Azacitidine—Dehydration—Doxorubicin—thyroid cancer	0.000719	0.000852	CcSEcCtD
Azacitidine—Dry skin—Doxorubicin—thyroid cancer	0.000708	0.00084	CcSEcCtD
Azacitidine—Vomiting—Sorafenib—thyroid cancer	0.000706	0.000838	CcSEcCtD
Azacitidine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000706	0.000837	CcSEcCtD
Azacitidine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000706	0.000837	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	0.000704	0.0164	CbGpPWpGaD
Azacitidine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000703	0.000834	CcSEcCtD
Azacitidine—Rash—Sorafenib—thyroid cancer	0.0007	0.000831	CcSEcCtD
Azacitidine—Dermatitis—Sorafenib—thyroid cancer	0.0007	0.00083	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—THRB—thyroid cancer	0.000697	0.0163	CbGpPWpGaD
Azacitidine—Headache—Sorafenib—thyroid cancer	0.000696	0.000825	CcSEcCtD
Azacitidine—Bronchitis—Epirubicin—thyroid cancer	0.000694	0.000823	CcSEcCtD
Azacitidine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000691	0.00082	CcSEcCtD
Azacitidine—Pancytopenia—Epirubicin—thyroid cancer	0.000685	0.000813	CcSEcCtD
Azacitidine—Muscular weakness—Doxorubicin—thyroid cancer	0.000682	0.000808	CcSEcCtD
Azacitidine—Dysuria—Epirubicin—thyroid cancer	0.000675	0.000801	CcSEcCtD
Azacitidine—Neutropenia—Epirubicin—thyroid cancer	0.000675	0.000801	CcSEcCtD
Azacitidine—Abdominal distension—Doxorubicin—thyroid cancer	0.000672	0.000798	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000671	0.000796	CcSEcCtD
Azacitidine—Dysphagia—Doxorubicin—thyroid cancer	0.000668	0.000792	CcSEcCtD
Azacitidine—Nausea—Sorafenib—thyroid cancer	0.00066	0.000783	CcSEcCtD
Azacitidine—Weight decreased—Epirubicin—thyroid cancer	0.000653	0.000775	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—TRIM33—thyroid cancer	0.000651	0.0152	CbGpPWpGaD
Azacitidine—Pneumonia—Epirubicin—thyroid cancer	0.000647	0.000768	CcSEcCtD
Azacitidine—Infestation NOS—Epirubicin—thyroid cancer	0.000644	0.000763	CcSEcCtD
Azacitidine—Infestation—Epirubicin—thyroid cancer	0.000644	0.000763	CcSEcCtD
Azacitidine—Bronchitis—Doxorubicin—thyroid cancer	0.000642	0.000762	CcSEcCtD
Azacitidine—Pancytopenia—Doxorubicin—thyroid cancer	0.000634	0.000752	CcSEcCtD
Azacitidine—Renal failure—Epirubicin—thyroid cancer	0.000633	0.00075	CcSEcCtD
Azacitidine—Stomatitis—Epirubicin—thyroid cancer	0.000627	0.000744	CcSEcCtD
Azacitidine—Urinary tract infection—Epirubicin—thyroid cancer	0.000626	0.000742	CcSEcCtD
Azacitidine—Dysuria—Doxorubicin—thyroid cancer	0.000625	0.000741	CcSEcCtD
Azacitidine—Neutropenia—Doxorubicin—thyroid cancer	0.000625	0.000741	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000621	0.000736	CcSEcCtD
Azacitidine—Haematuria—Epirubicin—thyroid cancer	0.000614	0.000728	CcSEcCtD
Azacitidine—CDA—Metabolism—HPGD—thyroid cancer	0.000611	0.0143	CbGpPWpGaD
Azacitidine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000609	0.000722	CcSEcCtD
Azacitidine—Epistaxis—Epirubicin—thyroid cancer	0.000607	0.00072	CcSEcCtD
Azacitidine—Weight decreased—Doxorubicin—thyroid cancer	0.000604	0.000717	CcSEcCtD
Azacitidine—Sinusitis—Epirubicin—thyroid cancer	0.000604	0.000716	CcSEcCtD
Azacitidine—Agranulocytosis—Epirubicin—thyroid cancer	0.000601	0.000712	CcSEcCtD
Azacitidine—Pneumonia—Doxorubicin—thyroid cancer	0.000599	0.000711	CcSEcCtD
Azacitidine—Infestation NOS—Doxorubicin—thyroid cancer	0.000595	0.000706	CcSEcCtD
Azacitidine—Infestation—Doxorubicin—thyroid cancer	0.000595	0.000706	CcSEcCtD
Azacitidine—Renal failure—Doxorubicin—thyroid cancer	0.000585	0.000694	CcSEcCtD
Azacitidine—Haemoglobin—Epirubicin—thyroid cancer	0.000581	0.000689	CcSEcCtD
Azacitidine—Stomatitis—Doxorubicin—thyroid cancer	0.00058	0.000689	CcSEcCtD
Azacitidine—Rhinitis—Epirubicin—thyroid cancer	0.000579	0.000687	CcSEcCtD
Azacitidine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000579	0.000687	CcSEcCtD
Azacitidine—Haemorrhage—Epirubicin—thyroid cancer	0.000578	0.000685	CcSEcCtD
Azacitidine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000575	0.000682	CcSEcCtD
Azacitidine—Pharyngitis—Epirubicin—thyroid cancer	0.000573	0.00068	CcSEcCtD
Azacitidine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000571	0.000677	CcSEcCtD
Azacitidine—Oedema peripheral—Epirubicin—thyroid cancer	0.000569	0.000675	CcSEcCtD
Azacitidine—Haematuria—Doxorubicin—thyroid cancer	0.000568	0.000674	CcSEcCtD
Azacitidine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000568	0.000673	CcSEcCtD
Azacitidine—Urethral disorder—Epirubicin—thyroid cancer	0.000566	0.000672	CcSEcCtD
Azacitidine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000563	0.000668	CcSEcCtD
Azacitidine—Epistaxis—Doxorubicin—thyroid cancer	0.000562	0.000666	CcSEcCtD
Azacitidine—Sinusitis—Doxorubicin—thyroid cancer	0.000559	0.000663	CcSEcCtD
Azacitidine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000556	0.000659	CcSEcCtD
Azacitidine—Eye disorder—Epirubicin—thyroid cancer	0.00054	0.00064	CcSEcCtD
Azacitidine—Haemoglobin—Doxorubicin—thyroid cancer	0.000537	0.000637	CcSEcCtD
Azacitidine—Cardiac disorder—Epirubicin—thyroid cancer	0.000536	0.000636	CcSEcCtD
Azacitidine—Rhinitis—Doxorubicin—thyroid cancer	0.000536	0.000636	CcSEcCtD
Azacitidine—Haemorrhage—Doxorubicin—thyroid cancer	0.000535	0.000634	CcSEcCtD
Azacitidine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000532	0.000631	CcSEcCtD
Azacitidine—Pharyngitis—Doxorubicin—thyroid cancer	0.000531	0.000629	CcSEcCtD
Azacitidine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000528	0.000626	CcSEcCtD
Azacitidine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000527	0.000625	CcSEcCtD
Azacitidine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000525	0.000623	CcSEcCtD
Azacitidine—Angiopathy—Epirubicin—thyroid cancer	0.000524	0.000622	CcSEcCtD
Azacitidine—Urethral disorder—Doxorubicin—thyroid cancer	0.000524	0.000622	CcSEcCtD
Azacitidine—Immune system disorder—Epirubicin—thyroid cancer	0.000522	0.000619	CcSEcCtD
Azacitidine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000521	0.000618	CcSEcCtD
Azacitidine—Chills—Epirubicin—thyroid cancer	0.000518	0.000615	CcSEcCtD
Azacitidine—Alopecia—Epirubicin—thyroid cancer	0.000511	0.000606	CcSEcCtD
Azacitidine—Mental disorder—Epirubicin—thyroid cancer	0.000506	0.0006	CcSEcCtD
Azacitidine—Malnutrition—Epirubicin—thyroid cancer	0.000503	0.000597	CcSEcCtD
Azacitidine—Erythema—Epirubicin—thyroid cancer	0.000503	0.000597	CcSEcCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—CCND1—thyroid cancer	0.000501	0.0117	CbGpPWpGaD
Azacitidine—Eye disorder—Doxorubicin—thyroid cancer	0.0005	0.000593	CcSEcCtD
Azacitidine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000496	0.000589	CcSEcCtD
Azacitidine—Back pain—Epirubicin—thyroid cancer	0.000486	0.000577	CcSEcCtD
Azacitidine—Angiopathy—Doxorubicin—thyroid cancer	0.000485	0.000575	CcSEcCtD
Azacitidine—Muscle spasms—Epirubicin—thyroid cancer	0.000484	0.000574	CcSEcCtD
Azacitidine—Immune system disorder—Doxorubicin—thyroid cancer	0.000483	0.000573	CcSEcCtD
Azacitidine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000482	0.000572	CcSEcCtD
Azacitidine—Chills—Doxorubicin—thyroid cancer	0.00048	0.000569	CcSEcCtD
Azacitidine—Alopecia—Doxorubicin—thyroid cancer	0.000472	0.00056	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—THRB—thyroid cancer	0.000471	0.011	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—TPR—thyroid cancer	0.000471	0.011	CbGpPWpGaD
Azacitidine—Mental disorder—Doxorubicin—thyroid cancer	0.000468	0.000556	CcSEcCtD
Azacitidine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000467	0.000554	CcSEcCtD
Azacitidine—Malnutrition—Doxorubicin—thyroid cancer	0.000465	0.000552	CcSEcCtD
Azacitidine—Erythema—Doxorubicin—thyroid cancer	0.000465	0.000552	CcSEcCtD
Azacitidine—Anaemia—Epirubicin—thyroid cancer	0.000465	0.000551	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	0.000464	0.0108	CbGpPWpGaD
Azacitidine—Malaise—Epirubicin—thyroid cancer	0.000454	0.000538	CcSEcCtD
Azacitidine—Syncope—Epirubicin—thyroid cancer	0.000451	0.000535	CcSEcCtD
Azacitidine—Leukopenia—Epirubicin—thyroid cancer	0.00045	0.000534	CcSEcCtD
Azacitidine—Back pain—Doxorubicin—thyroid cancer	0.00045	0.000534	CcSEcCtD
Azacitidine—Muscle spasms—Doxorubicin—thyroid cancer	0.000447	0.000531	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—MEN1—thyroid cancer	0.000442	0.0103	CbGpPWpGaD
Azacitidine—Loss of consciousness—Epirubicin—thyroid cancer	0.000442	0.000524	CcSEcCtD
Azacitidine—Cough—Epirubicin—thyroid cancer	0.000439	0.000521	CcSEcCtD
Azacitidine—Convulsion—Epirubicin—thyroid cancer	0.000436	0.000517	CcSEcCtD
Azacitidine—Hypertension—Epirubicin—thyroid cancer	0.000434	0.000515	CcSEcCtD
Azacitidine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000432	0.000512	CcSEcCtD
Azacitidine—Anaemia—Doxorubicin—thyroid cancer	0.00043	0.00051	CcSEcCtD
Azacitidine—Myalgia—Epirubicin—thyroid cancer	0.000428	0.000508	CcSEcCtD
Azacitidine—Chest pain—Epirubicin—thyroid cancer	0.000428	0.000508	CcSEcCtD
Azacitidine—Arthralgia—Epirubicin—thyroid cancer	0.000428	0.000508	CcSEcCtD
Azacitidine—Anxiety—Epirubicin—thyroid cancer	0.000427	0.000506	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000425	0.000504	CcSEcCtD
Azacitidine—Discomfort—Epirubicin—thyroid cancer	0.000423	0.000502	CcSEcCtD
Azacitidine—Malaise—Doxorubicin—thyroid cancer	0.00042	0.000498	CcSEcCtD
Azacitidine—Syncope—Doxorubicin—thyroid cancer	0.000417	0.000495	CcSEcCtD
Azacitidine—Leukopenia—Doxorubicin—thyroid cancer	0.000417	0.000494	CcSEcCtD
Azacitidine—Confusional state—Epirubicin—thyroid cancer	0.000414	0.000491	CcSEcCtD
Azacitidine—Anaphylactic shock—Epirubicin—thyroid cancer	0.00041	0.000487	CcSEcCtD
Azacitidine—Oedema—Epirubicin—thyroid cancer	0.00041	0.000487	CcSEcCtD
Azacitidine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000409	0.000485	CcSEcCtD
Azacitidine—Infection—Epirubicin—thyroid cancer	0.000408	0.000484	CcSEcCtD
Azacitidine—Cough—Doxorubicin—thyroid cancer	0.000406	0.000482	CcSEcCtD
Azacitidine—Shock—Epirubicin—thyroid cancer	0.000404	0.000479	CcSEcCtD
Azacitidine—Convulsion—Doxorubicin—thyroid cancer	0.000403	0.000478	CcSEcCtD
Azacitidine—Nervous system disorder—Epirubicin—thyroid cancer	0.000403	0.000478	CcSEcCtD
Azacitidine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000402	0.000477	CcSEcCtD
Azacitidine—Hypertension—Doxorubicin—thyroid cancer	0.000402	0.000477	CcSEcCtD
Azacitidine—Tachycardia—Epirubicin—thyroid cancer	0.000401	0.000475	CcSEcCtD
Azacitidine—Skin disorder—Epirubicin—thyroid cancer	0.000399	0.000473	CcSEcCtD
Azacitidine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000397	0.000471	CcSEcCtD
Azacitidine—Arthralgia—Doxorubicin—thyroid cancer	0.000396	0.00047	CcSEcCtD
Azacitidine—Chest pain—Doxorubicin—thyroid cancer	0.000396	0.00047	CcSEcCtD
Azacitidine—Myalgia—Doxorubicin—thyroid cancer	0.000396	0.00047	CcSEcCtD
Azacitidine—Anxiety—Doxorubicin—thyroid cancer	0.000395	0.000468	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000393	0.000467	CcSEcCtD
Azacitidine—Discomfort—Doxorubicin—thyroid cancer	0.000391	0.000464	CcSEcCtD
Azacitidine—Anorexia—Epirubicin—thyroid cancer	0.000391	0.000464	CcSEcCtD
Azacitidine—Hypotension—Epirubicin—thyroid cancer	0.000384	0.000455	CcSEcCtD
Azacitidine—Confusional state—Doxorubicin—thyroid cancer	0.000383	0.000454	CcSEcCtD
Azacitidine—Oedema—Doxorubicin—thyroid cancer	0.00038	0.000451	CcSEcCtD
Azacitidine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00038	0.000451	CcSEcCtD
Azacitidine—Infection—Doxorubicin—thyroid cancer	0.000377	0.000448	CcSEcCtD
Azacitidine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000374	0.000444	CcSEcCtD
Azacitidine—Shock—Doxorubicin—thyroid cancer	0.000374	0.000443	CcSEcCtD
Azacitidine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000372	0.000442	CcSEcCtD
Azacitidine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000372	0.000441	CcSEcCtD
Azacitidine—Insomnia—Epirubicin—thyroid cancer	0.000371	0.00044	CcSEcCtD
Azacitidine—Tachycardia—Doxorubicin—thyroid cancer	0.000371	0.00044	CcSEcCtD
Azacitidine—Skin disorder—Doxorubicin—thyroid cancer	0.000369	0.000438	CcSEcCtD
Azacitidine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000367	0.000436	CcSEcCtD
Azacitidine—Dyspnoea—Epirubicin—thyroid cancer	0.000366	0.000434	CcSEcCtD
Azacitidine—Anorexia—Doxorubicin—thyroid cancer	0.000362	0.000429	CcSEcCtD
Azacitidine—Dyspepsia—Epirubicin—thyroid cancer	0.000361	0.000429	CcSEcCtD
Azacitidine—Decreased appetite—Epirubicin—thyroid cancer	0.000357	0.000423	CcSEcCtD
Azacitidine—Hypotension—Doxorubicin—thyroid cancer	0.000355	0.000421	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000354	0.00042	CcSEcCtD
Azacitidine—Fatigue—Epirubicin—thyroid cancer	0.000354	0.00042	CcSEcCtD
Azacitidine—Pain—Epirubicin—thyroid cancer	0.000351	0.000416	CcSEcCtD
Azacitidine—Constipation—Epirubicin—thyroid cancer	0.000351	0.000416	CcSEcCtD
Azacitidine—CDA—Metabolism—TPR—thyroid cancer	0.000351	0.00819	CbGpPWpGaD
Azacitidine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000346	0.00041	CcSEcCtD
Azacitidine—CDA—Metabolism—PRKAR1A—thyroid cancer	0.000345	0.00806	CbGpPWpGaD
Azacitidine—Insomnia—Doxorubicin—thyroid cancer	0.000344	0.000407	CcSEcCtD
Azacitidine—Dyspnoea—Doxorubicin—thyroid cancer	0.000339	0.000402	CcSEcCtD
Azacitidine—Feeling abnormal—Epirubicin—thyroid cancer	0.000338	0.000401	CcSEcCtD
Azacitidine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000336	0.000398	CcSEcCtD
Azacitidine—Dyspepsia—Doxorubicin—thyroid cancer	0.000334	0.000397	CcSEcCtD
Azacitidine—Decreased appetite—Doxorubicin—thyroid cancer	0.00033	0.000392	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000328	0.000389	CcSEcCtD
Azacitidine—Fatigue—Doxorubicin—thyroid cancer	0.000327	0.000388	CcSEcCtD
Azacitidine—Urticaria—Epirubicin—thyroid cancer	0.000326	0.000387	CcSEcCtD
Azacitidine—Pain—Doxorubicin—thyroid cancer	0.000325	0.000385	CcSEcCtD
Azacitidine—Constipation—Doxorubicin—thyroid cancer	0.000325	0.000385	CcSEcCtD
Azacitidine—Body temperature increased—Epirubicin—thyroid cancer	0.000324	0.000385	CcSEcCtD
Azacitidine—Abdominal pain—Epirubicin—thyroid cancer	0.000324	0.000385	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—TPR—thyroid cancer	0.000318	0.00742	CbGpPWpGaD
Azacitidine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000313	0.000371	CcSEcCtD
Azacitidine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000311	0.000368	CcSEcCtD
Azacitidine—Hypersensitivity—Epirubicin—thyroid cancer	0.000302	0.000359	CcSEcCtD
Azacitidine—Urticaria—Doxorubicin—thyroid cancer	0.000302	0.000358	CcSEcCtD
Azacitidine—Body temperature increased—Doxorubicin—thyroid cancer	0.0003	0.000356	CcSEcCtD
Azacitidine—Abdominal pain—Doxorubicin—thyroid cancer	0.0003	0.000356	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—MEN1—thyroid cancer	0.000299	0.00698	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RXRA—thyroid cancer	0.000296	0.00691	CbGpPWpGaD
Azacitidine—Asthenia—Epirubicin—thyroid cancer	0.000295	0.000349	CcSEcCtD
Azacitidine—Pruritus—Epirubicin—thyroid cancer	0.00029	0.000344	CcSEcCtD
Azacitidine—Diarrhoea—Epirubicin—thyroid cancer	0.000281	0.000333	CcSEcCtD
Azacitidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00028	0.000332	CcSEcCtD
Azacitidine—Asthenia—Doxorubicin—thyroid cancer	0.000272	0.000323	CcSEcCtD
Azacitidine—Dizziness—Epirubicin—thyroid cancer	0.000271	0.000322	CcSEcCtD
Azacitidine—Pruritus—Doxorubicin—thyroid cancer	0.000269	0.000319	CcSEcCtD
Azacitidine—CDA—Metabolism—SLC5A5—thyroid cancer	0.000263	0.00613	CbGpPWpGaD
Azacitidine—Vomiting—Epirubicin—thyroid cancer	0.000261	0.00031	CcSEcCtD
Azacitidine—Diarrhoea—Doxorubicin—thyroid cancer	0.00026	0.000308	CcSEcCtD
Azacitidine—Rash—Epirubicin—thyroid cancer	0.000259	0.000307	CcSEcCtD
Azacitidine—Dermatitis—Epirubicin—thyroid cancer	0.000259	0.000307	CcSEcCtD
Azacitidine—Headache—Epirubicin—thyroid cancer	0.000257	0.000305	CcSEcCtD
Azacitidine—Dizziness—Doxorubicin—thyroid cancer	0.000251	0.000298	CcSEcCtD
Azacitidine—Nausea—Epirubicin—thyroid cancer	0.000244	0.000289	CcSEcCtD
Azacitidine—Vomiting—Doxorubicin—thyroid cancer	0.000241	0.000286	CcSEcCtD
Azacitidine—Rash—Doxorubicin—thyroid cancer	0.000239	0.000284	CcSEcCtD
Azacitidine—Dermatitis—Doxorubicin—thyroid cancer	0.000239	0.000284	CcSEcCtD
Azacitidine—Headache—Doxorubicin—thyroid cancer	0.000238	0.000282	CcSEcCtD
Azacitidine—Nausea—Doxorubicin—thyroid cancer	0.000226	0.000268	CcSEcCtD
Azacitidine—CDA—Metabolism—RXRA—thyroid cancer	0.000221	0.00515	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RXRA—thyroid cancer	0.0002	0.00467	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PPARG—thyroid cancer	0.000187	0.00436	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PPARG—thyroid cancer	0.000139	0.00325	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PPARG—thyroid cancer	0.000126	0.00295	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTGS2—thyroid cancer	0.00011	0.00256	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PTEN—thyroid cancer	9.56e-05	0.00223	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AKT1—thyroid cancer	7.39e-05	0.00173	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKT1—thyroid cancer	5.51e-05	0.00129	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AKT1—thyroid cancer	4.99e-05	0.00117	CbGpPWpGaD
